It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2017.
2017 | Chennai, Tamil Nadu, India | ActiveHermadis Pharmaceuticals Private Limited, a active private limited company, was established on 19 September 2017 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999TN2017PTC118685. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Anbalagan Kumaresan (Director), Sudha (Additional Director). Past directors included Sounderajan Dinesh Babu, Vajravelu Vignesh. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at No.11/256, First Floor, Guru Appts, Rajarajan Street, Bharathi Nagar, Polich, Alur, Chennai, Tamil Nadu, 600074.
U74999TN2017PTC118685
118685
19 September 2017
₹1.00 M
₹0.10 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Hermadis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anbalagan Kumaresan | Director | 19 Sep 2017 | Current |
| Sudha | Additional Director | 03 May 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Jul 2018 | Past |
| Pramod Abcsdd | Director | 03 May 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hermadis Pharmaceuticals Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2018, Hermadis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Hermadis Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hermadis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hermadis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Hermadis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
Hermadis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chennai. was recorded as a recent event.
Progress on Sudha was appointed as a Additional Director was appointed as a Additional Director on 03 May 2021 & has been associated with this company since 4 years 7 months . was documented.
Anbalagan Kumaresan was appointed as a Director was appointed as a Director on 19 Sep 2017 & has been associated with this company since 8 years 3 months . was recorded as a recent event.
The activity Hermadis Pharmaceuticals Private Limited was registered on 19 Sep 2017 with Roc Chennai & aged 8 years 3 months as per MCA records. was completed.
The CIN of Hermadis Pharmaceuticals Private Limited is U74999TN2017PTC118685.
Hermadis Pharmaceuticals Private Limited is headquartered at No.11/256, First Floor, Guru Appts, Rajarajan Street, Bharathi Nagar, Polich, Alur, Chennai, Tamil Nadu, 600074.
Hermadis Pharmaceuticals Private Limited was incorporated on 19 September 2017.
The current directors of Hermadis Pharmaceuticals Private Limited are
The primary industry of Hermadis Pharmaceuticals Private Limited is Trade.
Hermadis Pharmaceuticals Private Limited is unlisted.
The authorized capital of Hermadis Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Hermadis Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX